LEADER 01325nam  2200433   450 
001 9910555164403321
005 20191111074841.0
010   $a1-118-67583-5
010   $a1-118-67577-0
010   $a1-118-67574-6
035   $a(CKB)4330000000006745
035   $a(MiAaPQ)EBC5940462
035   $a(PPN)243211341
035   $a(EXLCZ)994330000000006745
100   $a20191111d2020      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aIn vitro drug release testing of special dosage forms /$fedited by Nikoletta Fotaki, Sandra Klein
210  1$aHoboken, New Jersey ;$aChichester, West Sussex, England :$cWiley,$d[2020]
210  4$dİ2020
215   $a1 online resource (315 pages)
225 1 $aAdvances in pharmaceutical technology
311   $a1-118-34147-3 
410  0$aAdvances in pharmaceutical technology.
606   $aSolid dosage forms
615  0$aSolid dosage forms.
676   $a615.19 
702   $aFotaki$b Nikoletta$f1973-
702   $aKlein$b Sandra$f1970-
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910555164403321
996   $aIn vitro drug release testing of special dosage forms$92817053
997   $aUNINA